Dabigatran etexilate

Details

Files

Generic Name:

Dabigatran etexilate

Project Status:

Complete

Therapeutic Area:

Thromboembolism (venous), prevention

Manufacturer:

Boehringer Ingelheim (Canada) Ltd.

Brand Name:

Pradaxa

Project Line:

Reimbursement Review

Project Number:

SR0140-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Thromboembolism (venous), prevention

Recommendation Type:

Do not list

Final Recommendation:

January 28, 2009

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : July 8, 2008